$ACAD CEO Steve Davis will be speaking at the JPM conference tomorrow at 2:00 eastern. Last year he gave one of his best speeches ever, and the stock rose $1.35 the following day. If he can explain just how massive the DRP market is, and why doctors will not be prescribing any antipsychotic for DRP other than Nuplazid, we should see a jump in the price Wednesday.
  • 6